Investment
Features
FeesSafety
Academy
More
Pluang+

Solis Minerals launches 5,000m drilling at Peru's Cucho Copper Project targeting large copper-molybdenum system.

Market News
19 Oct 2026
Proactive Investors
View Source
Bullish
Solis Minerals launches 5,000m drilling at Peru's Cucho Copper Project targeting large copper-molybdenum system.

Solis Minerals is starting a 5,000-metre diamond drilling program at its Cucho Copper Project in Peru, focusing on three priority zones within an expanding copper-molybdenum system. Recent geological work has extended the target area and identified a large porphyry system, with surface samples showing promising copper and molybdenum values. The initial drilling will test these zones, with flexibility to expand based on results. This follows historical drilling that confirmed broad mineralisation, and Solis holds rights to acquire up to 100% of the project under a joint venture. Drilling is set to begin in October, with further exploration ongoing at other projects in Peru and Brazil.

Solis Minerals' upcoming 5,000-metre drilling program at the Cucho Copper Project in Peru is noted here alongside Pluang's Basic Materials sector data. For readers following Basic Materials, here is Pluang's market snapshot as of Oct 20, 2026 07:11 WIB: of 83 priced US stocks, 30 rose and 51 fell. Notable prices include Steel Dynamics Inc. (STLD) at USD 233.94 with a -2.74% change and a typical hold time of 11 days, Nutrien Ltd (NTR) at USD 69.31 with a -2.74% change and 100% buy order activity, and Aura Minerals Inc. (AUGO) at USD 84.83 with a -2.72% change and a 5-day typical hold time.

More News

XBiotech's phase II trial shows 61.3% 12-month survival in refractory metastatic colorectal cancer with vilamakitug.

XBiotech's phase II trial shows 61.3% 12-month survival in refractory metastatic colorectal cancer with vilamakitug.

XBiotech announced positive final efficacy results from its phase II TASKIN trial for vilamakitug (XB2001) in refractory metastatic colorectal cancer. The study, funded by the French National Cancer Institute, showed a 61.3% overall survival rate at ...

Company Fundamentals
Bullish
2 hours ago
Phase II study shows Vilamakitug improves 12-month survival in refractory metastatic colorectal cancer.

Phase II study shows Vilamakitug improves 12-month survival in refractory metastatic colorectal cancer.

XBiotech announced positive final results from the Phase II TASKIN study, showing that adding Vilamakitug (XB2001) to standard chemotherapy improved 12-month overall survival to 61.3% in patients with refractory metastatic colorectal cancer, surpassi...

Market News
Bullish
2 hours ago
Dorchester Minerals to acquire 4,300 net royalty acres in North Dakota's Williston Basin

Dorchester Minerals to acquire 4,300 net royalty acres in North Dakota's Williston Basin

Dorchester Minerals, L.P. has agreed to acquire mineral and royalty interests covering about 4,300 net royalty acres in three counties within North Dakota's Williston Basin. The deal involves a non-taxable contribution and exchange agreement with an ...

Company Fundamentals
Bullish
3 hours ago
Hershey Trust sells shares ahead of Q3 earnings, retaining control amid price hikes and volume drop.

Hershey Trust sells shares ahead of Q3 earnings, retaining control amid price hikes and volume drop.

The Hershey Trust Company sold 1,512 common shares under a trading plan but kept voting control through Class B shares. Hershey will report Q3 earnings on October 29, with investors focused on how price increases affected Halloween-season demand. Q2 ...

Market News
Neutral
4 hours ago
W. R. Berkley Q3 2026 earnings beat EPS estimates but revenue dips, net income down 13%.

W. R. Berkley Q3 2026 earnings beat EPS estimates but revenue dips, net income down 13%.

W. R. Berkley reported mixed Q3 2026 results with earnings per share of $1.17 beating estimates, but revenue fell short at $3.74 billion versus $3.82 billion expected. The company saw premium growth with gross premiums up 3% and net premiums up 1%, s...

Company Fundamentals
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App